LAUSANNE, Switzerland — Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced today the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA samples. BRB-seq is Alithea’s flagship technology and is based on early sample barcoding and pooling. With BRB-seq, […]

BC|GENOME X-10 provides a complete solution for high quality, high throughput NGS laboratory operations. BC Platforms (BCP), a global leader in healthcare data management and analytics, and US-based Sentieon, ​a developer of highly optimized algorithms for bioinformatics applications, today announced the launch of its new integrated next generation sequencing (NGS) genetic analytics software, known as BC|GENOME X-10. BC|GENOME X-10 has been […]

The two companies join forces to develop tools and software compliant with the ISO/IEC 23092 MPEG-G international open standard for genome sequencing. Lausanne –GenomSys has signed a multi-year development and license agreement with Philips, a global leader in health technology, to develop tools and software compliant with the ISO/IEC 23092 MPEG-G international open standard for […]

WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher’s Life Sciences segment. ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life […]

WOBURN, MA — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the pricing of its initial public offering of 3,060,000 shares of its common stock and accompanying warrants to purchase up […]

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients with isocitrate dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) who may be candidates for Servier Pharmaceuticals’ […]

IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of its newest loop-mediated isothermal amplification (LAMP) products: the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix (with UDG) and the WarmStart Fluorescent LAMP/RT-LAMP Kit (with UDG), which combines the master mix and LAMP fluorescent dye in one convenient kit. The new master mix and kit enable researchers to […]

Highly accurate HRD detection offers affordable and easily implementable solutions, opening new doors for healthcare São Paulo, Brazil and Boston, MA – Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to offer the first decentralized HRD (Homologous recombination deficiency) analytics solution in Latin […]

Milestone underlines company’s global leadership in sample preparation Company’s NGS assays also hit milestone of one million samples tested since 2015 New kits and instruments will bolster QIAGEN’s position in most crucial area of molecular testing GERMANTOWN, Md. & HILDEN, Germany– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the number of biological […]

The new approach will be tested in three cohorts of patients diagnosed with Cystic Fibrosis, Alzheimer’s Disease, and Coronary Artery Disease ATLANTA, GA, UNITED STATES — Sequegenics today announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $251,073 to conduct research and development (R&D) work on a new approach […]